CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

This research trial studies carbonic anhydrase 9 (CA-IX), p16, proliferative markers, and human papilloma virus (HPV) in diagnosing cervical lesions in patients with abnormal cervical cells. Studying biomarkers in abnormal cervical cells may improve the ability to find cervical lesions and plan effective treatment.

Research Base: Gynecologic Oncology Group
NCT ID: NCT00892866
NCI Protocol Number: GOG-0237
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Cytology Specimen Collection Procedure; Laboratory Biomarker Analysis

Condition

Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Human Papillomavirus Infection, Stage 0 Cervical Cancer AJCC v7

Trial Type

Cancer Prevention

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP